it has shown no detectable binding to cells from aml patients in remission ( 0/3 ) , patients with chronic myelogenous leukemia in chronic phase ( cml ) ( 0/7 ) , normal bone marrow ( 0/9 ) , normal peripheral blood mononuclear cells , granulocytes , platelets , erythrocytes , monocytes , or splenocytes by radioimmunoassay or fluorescence analysis using flow cytometry .
C0023473
chronic myelogenous leukemia
C0005953
bone marrow